Adaptive Biotechnologies Corp expected to post a loss of 35 cents a share - Earnings Preview

Adaptive Biotechnologies

01/08/2023 03:03

* Adaptive Biotechnologies Corp  ADPT.OQ   ADPT.O  is
expected
to show a rise in quarterly revenue when it reports  results on
August 2. 
    * The Seattle Washington-based  company is expected to
report  a
2.8% increase in revenue to $44.887 million from $43.66 million
a year ago, according to the mean estimate from 9 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Adaptive
Biotechnologies
Corp is for a loss of 35 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $12​, above​ its last closing price
of $8.44. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.37       -0.38      -0.40     Missed  -6.2
 Dec. 31 2023  -0.34       -0.35      -0.28     Beat    19.2
 Sep. 30 2022  -0.37       -0.38      -0.32     Beat    14.9​
 Jun. 30 2022  -0.41       -0.43      -0.37     Beat    14
 ​​Mar.        -0.45       -0.46      -0.44     Beat    4.1
 31 2022                                                
 Dec. 31 2021  -0.47       -0.45      -0.43     Beat    4.7​
 Sep. 30 2021  -0.42       -0.42      -0.40     Beat    5
 Jun. 30 2021  -0.42       -0.43      -0.35     Beat    18.1
 This summary was machine generated August 1 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated